| Name | Title | Contact Details |
|---|
Turn One is a manufacturer of high performance power steering boxes, pumps, pulleys and accessories. We also offer rebuilding services for power steering boxes, pumps, and rack & pinion assemblies. Delivering the highest quality parts for drivers that demand the best in steering performance!
BKD CPAs & Advisors is a top-tier CPA and advisory firm dedicated to helping people and businesses realize their goals. Our approximately 2,900 dedicated professionals offer solutions to clients in all 50 states and internationally. Our expertise goes well beyond the standard accounting services to include risk management, technology, wealth management and forensic and valuation services. Our clients represent a wide range of industries, and were even part of an alliance of firms that gives us a global reach.
Geneva Consulting Group (GCG) is a global network of Management Consulting Firms. We support companies and entrepreneurs across many different countries and industries in important decisions related to strategy, organisation & HR, technology, turnaround & transformation. Whether in Spain, the United States, Indonesia or Argentina, our firms share one common mindset – a ‘can do entrepreneurial vision and attitude. But more so in GCG, our independent minds take pride in providing a fresh perspective, working collaboratively across the world.
BenefitHelp brings a menu of innovative solutions to help employers control costs and achieve a healthier, happier, more productive workforce. We use proven processes and technologies that help employers communicate, enroll, and administer their employee benefits programs. BenefitHelp has a range of services that address the entire benefit package, multi-media communication tools like the BenefitMOVIE www.BenefitMOVIE.com, multiple enrollment solutions, and a full benefit administration systems. Todays environment mandates that employers and employees become more educated consumers of Health Care & Benefit Plans. Our goal is to enhance the value of businesses by providing them innovative solutions that bring cost savings, education and benefit enrichment. As stated by Mark Holland, CEO,: "With our service everybody wins. Employers benefit because the employees better understand and appreciate their benefit package, as well as how much the employer spends; and employees benefit because they now understand and appreciate their benefits and how to use them." Studies show that people generally remember 10% of what they read, 10% of what they hear, 30% of what they see, and 50% of what they see and hear. Our multimedia approach provides the optimal solution because employees are reading, seeing, and hearing about their benefits. Visit us: www.BenefitHELP.com www.BenefitHELP.com/HowWeHelp.aspx www.BenefitMOVIE.com
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.